Kala制药(KALA)

2.9915 -0.3585 -10.7015%

今开:2.8565昨收:3.35
最高:3.01 最低:2.75
涨停价:0.0跌停价:0.0
总市值:1.93377635E8

Kala制药的热门评论

Takeabreak06-18 22:39

$安帝君斯(AGEN)$ $Kala制药(KALA)$ $Affimed(AFMD)$ BCYC, CGEN 这些都很强势!守住不动,同时间 XBI往下0.8%+。AMRS更是往上1%。吹票时间到了!![加油]查看全文

Spica07-18 19:54

回复@Takeabreak: 我问了下一位做干眼症的朋友,他是这么回复的“”Eysuvis 应该还不错,但不会成为重磅。重要的原因:lotemax一直被off label用作治疗干眼,$Kala制药(KALA)$ 只是改了一个剂型,把off label变成approved。Lotemax医生可以随便开的,会一定程度限制了Eysuvis销售“//@Takeabreak:...查看全文

Takeabreak07-26 21:10

$Kala制药(KALA)$ Symphony Health sales and volume estimates are as follows: For the week ending July 16, 2021: INVELTYS: Approximately $828k (MBS Dollars) in sales and 2,985 pack units (both up +20.7% week-over-week) -About 74% were from new prescriptions and 26% from refill...查看全文

Takeabreak07-22 11:50

$Karyopharm(KPTI)$ $G1治疗(GTHX)$ $Kala制药(KALA)$ BTAI. Value destroyers?? Commercialization is more risky. Lesson learned??? Or patience is a virtue ??查看全文

Takeabreak06-07 22:17

$Kala制药(KALA)$ 出坑了!! 1. 天热了, 要开空调了, 干眼症要爆发了! 2. 疫苗都打好了, 该找医生的要去找医生了! 看到有竟然目标价设40刀的!!!查看全文

7X24快讯06-08 00:02

美股纳米生物概念股集体上涨,Arbutus生物制药涨超17%,太平洋生物科技涨超7%,剪头制药、诺瓦瓦克斯医药涨超5%,Selecta生物科学、Kala制药涨超4%。查看全文

Takeabreak05-07 11:19

$Kala制药(KALA)$ 6刀5刀分别加了,浮亏较大。KPTI,BTAI,GTHX 也都不行,好在轻仓,确实只能是value play查看全文

Takeabreak04-23 21:56

$Kala制药(KALA)$ 重新站上8刀。财报有花头。今年目标15刀查看全文

Kala制药(KALA)05-06 04:06

$Kala制药(KALA)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-21-005904 Act: 34 Size: 6 MB 网页链接查看全文

美股市场有望回暖,这两只小摩所选股真能直冲云霄?

美股研究社04-15 17:24

本文作者:Marty Shtrubel 根据摩根大通首席执行官杰米•戴蒙(Jamie Dimon)的说法,美国正处于经济繁荣的风口浪尖,这种繁荣至少可以推动到2023年。戴蒙将强劲增长的前景归因于几个原因。 戴蒙表示:“我毫不怀疑,随着过度储蓄、新的刺激性储蓄、巨额赤字支出、更多的量化宽松政策、新的潜在基础...查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Kala制药的最新评论

当期报告

Kala制药(KALA)08-05 19:06

$Kala制药(KALA)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001558370-21-010375 Act: 34 Size: 385 KB 网页链接查看全文

Takeabreak07-26 21:10

$Kala制药(KALA)$ Symphony Health sales and volume estimates are as follows: For the week ending July 16, 2021: INVELTYS: Approximately $828k (MBS Dollars) in sales and 2,985 pack units (both up +20.7% week-over-week) -About 74% were from new prescriptions and 26% from refill...查看全文

Takeabreak07-22 11:50

$Karyopharm(KPTI)$ $G1治疗(GTHX)$ $Kala制药(KALA)$ BTAI. Value destroyers?? Commercialization is more risky. Lesson learned??? Or patience is a virtue ??查看全文

Spica07-18 19:54

回复@Takeabreak: 我问了下一位做干眼症的朋友,他是这么回复的“”Eysuvis 应该还不错,但不会成为重磅。重要的原因:lotemax一直被off label用作治疗干眼,$Kala制药(KALA)$ 只是改了一个剂型,把off label变成approved。Lotemax医生可以随便开的,会一定程度限制了Eysuvis销售“//@Takeabreak:...查看全文

Kala制药(KALA)07-01 07:33

$Kala制药(KALA)$ 内部交易: 2021-06-29,CHIEF SCIENTIFIC OFFICER,Chen Hongming ,卖出,5548普通股, $5.56查看全文

持股变动声明

Kala制药(KALA)07-01 05:36

$Kala制药(KALA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-21-003271 Size: 5 KB 网页链接查看全文

Kala制药(KALA)06-30 07:33

$Kala制药(KALA)$ 内部交易: 2021-06-28,CHIEF EXECUTIVE OFFICER,Iwicki Mark T ,卖出,7586普通股, $5.77查看全文

Kala制药(KALA)06-30 07:33

$Kala制药(KALA)$ 内部交易: 2021-06-28,CHIEF FINANCIAL OFFICER,Reumuth Mary ,卖出,2452普通股, $5.77查看全文

Kala制药(KALA)06-30 07:33

$Kala制药(KALA)$ 内部交易: 2021-06-28,SEE REMARKS,Trachtenberg Eric ,卖出,2452普通股, $5.77查看全文

Kala制药(KALA)06-30 07:33

$Kala制药(KALA)$ 内部交易: 2021-06-28,CHIEF SCIENTIFIC OFFICER,Chen Hongming ,卖出,2452普通股, $5.77查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Kala制药的公告

$Kala Pharmaceuticals, Inc.(KALA)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2018-10-05 AccNo: 0001144204-18-052764 Size: 41 KB 网页链接

$Kala Pharmaceuticals, Inc.(KALA)$ 424B2 - Prospectus [Rule 424(b)(2)] Filed: 2018-10-02 AccNo: 0001047469-18-006543 Size: 949 KB 网页链接

$Kala Pharmaceuticals, Inc.(KALA)$ 8-K - Current report Filed: 2018-10-05 AccNo: 0001104659-18-060617 Size: 361 KBItem 1.01: Entry into a Material Definitive AgreementItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接

$Kala Pharmaceuticals, Inc.(KALA)$ 8-K - Current report Filed: 2018-10-02 AccNo: 0001104659-18-060023 Size: 389 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接

$Kala Pharmaceuticals, Inc.(KALA)$ 8-K - Current report Filed: 2018-10-02 AccNo: 0001104659-18-060021 Size: 1 MBItem 1.01: Entry into a Material Definitive AgreementItem 1.02: Termination of a Material Definitive AgreementItem 2.03: Creation of a Direct Financial Obligation o...

$Kala Pharmaceuticals, Inc.(KALA)$ 424B2 - Prospectus [Rule 424(b)(2)] Filed: 2018-10-03 AccNo: 0001047469-18-006555 Size: 947 KB 网页链接

$Kala Pharmaceuticals, Inc.(KALA)$ 424B2 - Prospectus [Rule 424(b)(2)] Filed: 2018-10-02 AccNo: 0001047469-18-006543 Size: 949 KB 网页链接

$Kala Pharmaceuticals, Inc.(KALA)$ 内部交易: 2018-10-03,Director,RA CAPITAL MANAGEMENT, LLC ,买入,2424242普通股, $8.25

$Kala Pharmaceuticals, Inc.(KALA)$ 内部交易: 2018-10-03,Director,Shah Rajeev M. ,买入,2424242普通股, $8.25

$Kala Pharmaceuticals, Inc.(KALA)$ CORRESP [Cover] - Correspondence Filed: 2018-08-23 AccNo: 0001558370-18-007195 Size: 14 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24